{"nct_id":"NCT05664217","title":"NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma","status":"TERMINATED","status_verified_date":"2025-02","start_date":"2022-12-23","start_date_type":"ACTUAL","primary_completion_date":"2024-05-22","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-16","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["NKTR"]}